UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013565
Receipt number R000015850
Scientific Title Treatment effects of Endoscopic Cardiac Mucosal Resection (CMR) for refractory gastroesophageal reflux disease (GERD): a prospective study
Date of disclosure of the study information 2014/03/30
Last modified on 2017/04/03 16:30:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Treatment effects of Endoscopic Cardiac Mucosal Resection (CMR) for refractory gastroesophageal reflux disease (GERD): a prospective study

Acronym

Endoscopic Cardiac Mucosal Resection (CMR) for refractory gastroesophageal reflux disease (GERD)

Scientific Title

Treatment effects of Endoscopic Cardiac Mucosal Resection (CMR) for refractory gastroesophageal reflux disease (GERD): a prospective study

Scientific Title:Acronym

Endoscopic Cardiac Mucosal Resection (CMR) for refractory gastroesophageal reflux disease (GERD)

Region

Japan


Condition

Condition

Refractory gastroesophageal reflux disease

Classification by specialty

Gastroenterology Gastrointestinal surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study was to investigate the treatment efficacy of endoscopic cardiac mucosal resection (CMR) for refractory gastroesophageal reflux disease.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Treatment efficacy (subjective and objective symptom)

Key secondary outcomes

Treatment completion rate
Incidence of complication rate
Recurrence rate


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

Medication with endoscopic cardiac mucosal resection for refractory gastroesophageal reflux disease.

Interventions/Control_2

Medication without endoscopic cardiac mucosal resection for refractory gastroesophageal reflux disease.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) histologically proven adenocarcinoma.
(2) age 20-80 years.
(3) sufficient organ function.
(4) Performance status(ECOG) 0 to 1.
(4) Having written informed consent

Key exclusion criteria

(1) Any patients judged to be unfit to participate in the study, by the investigator.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Haruhiro Inoue, MD, PhD

Organization

Showa University Koto-Toyosu Hospital

Division name

Digestive Disease Center

Zip code


Address

5-1-38 Toyosu, Koto-ku, Tokyo 135-8577 Japan

TEL

03-6204-6000

Email

haruinoue777@yahoo.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Haruhiro Inoue, MD, PhD

Organization

Showa University Koto-Toyosu Hospital

Division name

Digestive Disease Center

Zip code


Address

5-1-38 Toyosu, Koto-ku, Tokyo 135-8577 Japan

TEL

03-6204-6000

Homepage URL


Email

haruinoue777@yahoo.co.jp


Sponsor or person

Institute

Digestive Disease Center, Showa University Koto-Toyosu Hospital

Institute

Department

Personal name



Funding Source

Organization

None.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 03 Month 30 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2012 Year 05 Month 01 Day

Date of IRB


Anticipated trial start date

2012 Year 06 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 03 Month 30 Day

Last modified on

2017 Year 04 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015850


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name